Expression of human-Torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG)

Clinical and Experimental Immunology

Volumn 109, Issue 3, 1997, Pages 538-546

  Loutrari, H ^a   Kokla, A ^a   Trakas, N ^a   Tzartos, S J ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Acetylcholine receptor; Epitope mapping; Myasthenia gravis

Indexed keywords

ANTIBODY; AUTOANTIGEN; CHOLINERGIC RECEPTOR; EPITOPE;

ALPHA CHAIN; ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; BINDING SITE; CROSS REACTION; CYTOLYSIS; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TORPEDO;

EID: 0030881226     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4701367.x     Document Type: Article

References (37)

1. Unwin N. Neurotransmitter action: Opening of ligand-gated ion channels. Cell (Suppl.) 1993; 72:31-41.
2. Galzi JL, Changeux JP. Neurotransmitter-gated ion channels as unconventional allosteric proteins. Curr Opin Struct Biol 1994; 4:554-65.
3. Karlin A. Explorations of the nicotinic acetylcholine receptor. Harvey Lect Ser 1991; 85:71-107.
4. Devillers-Thiery A, Galzi JL, Eisele JL, Bertrand S, Bertrand D, Changeux JP. Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels. J Membr Biol 1993; 136:97-112.
5. Claudio T. Molecular genetics of acetylcholine receptor-channels. In: Glover D, Hames D, eds. Frontiers of molecular biology. Oxford: IRL Press, 1989:63-142.
6. Lindstrom J, Shelton D, Fugii Y. Myasthenia gravis. Adv Immunol 1988; 42:233-84.
7. Conti-Tronconi BM, McLane KE, Raftery MA, Grando SA, Protti MP. The nicotinic acetylcholine receptor: structure and autoimmune pathology. Crit Rev Bioch Mol Biol 1994; 29:69-123.
8. Tzartos SJ, Seybold M, Lindstrom J. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc Natl Acad Sci USA 1982; 79:188-92.
9. Heidenreich F, Vincent A, Roberts A, Newsom-Davis J. Epitopes on human acetylcholine receptor defined by monoclonal antibodies and myasthenia gravis sera. Autoimmunity 1988; 1:285-97.
10. Tzartos SJ, Lindstrom JL. Monoclonal antibodies to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits. Proc Natl Acad Sci USA 1980; 77:755-9.
11. Tzartos SJ, Rand DE, Einarson BE, Lindstrom JM. Mapping of surface structures of Electrophorus acetylcholine receptor using monoclonal antibodies. J Biol Chem 1981; 256:8635-45.
12. Beroukhim R, Unwin N. Three-dimensional location of the main immunogenic region of the acetylcholine receptor. Neuron 1995; 15:323-31.
13. Lennon VA, Griesmann GE. Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis. Neurology 1989; 39:1069-76.
14. Mamalaki A, Tzartos SJ. Nicotinic acetylcholine receptor: structure, function and main immunogenic region. Adv Neuroimmunol 1994; 4:339-54.
15. Loutrari H, Tzartos SJ, Claudio T. Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the α-subunit in myasthenia gravis antisera. Eur J Immunol 1992; 22:2949-56.
16. Schoepfer R, Luther M, Lindstrom J. The human medulloblastoma cell line TE671 expresses a muscle-like acetylcholine receptor. Cloning of the α-subunit cDNA. FEBS Lett 1988; 226:235-40.
17. Claudio T, Green WN, Hartman DS, Hayden D, Paulson HL, Sigworth FJ, Sine SM, Swedlund A. Genetic reconstitution of functional acetylcholine receptor channels in mouse fibroblasts. Science 1987; 238:1688-93.
18. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7:2745-52.
19. Tzartos SJ, Kokla A, Walgrave S, Conti-Tronconi BM. Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the α-subunit. Proc Natl Acad Sci USA 1988; 85:2899-903.
20. Tzartos SJ, Loutrari HV, Tang F, Kokla A, Walgrave SL, Milius RP, Conti-Tronconi BM. Main immunogenic region of Torpedo electroplax and human muscle acetylcholine receptor. Localization and microheterogeneity revealed by the use of synthetic peptides. J Neurochem 1990; 54:51-61.
21. Tzartos SJ, Valkana C, Kouvatsou R, Kokla A. The tyrosine phosphorylation site of the acetylcholine receptor β subunit is located in a highly immunogenic epitope implicated in channel function: antibody probes tor β subunit phosphorylation and function. EMBO J 1993; 12:5141-9.
22. Tzartos SJ, Kouvatsou R, Tzartos E. Monoclonal antibodies as site-specific probes for the acetylcholine receptor δ-subunit tyrosine and serine phosphorylation sites. Eur J Biochem 1995; 228:463-72.
23. Tzartos SJ, Tzartos E, Tzartos J. Monoclonal antibodies against the acetylcholine receptor γ-subunit as site specific probes for receptor tyrosine phosphorylation. FEBS Letters 1995; 363:195-8.
24. Kordossi AA, Tzartos SJ. Monoclonal antibodies against the main immunogenic region of the acetylcholine receptor. Mapping on the intact molecule. J Neuroimmunol 1989; 23:35-40.
25. Tzartos SJ, Starzinski-Powitz A. Decrease in acetylcholine receptor content of human myotube cultures mediated by monoclonal antibodies to α, β and γ subunits. FEBS Letters 1986; 196:91-95.
26. Lindstrom J, Einarson B, Tzartos SJ. Production and assay of antibodies to acetylcholine receptor. Methods Enzymol 1981; 74:432-60.
27. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4.
28. Sophianos D, Tzartos SJ. Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against degradation caused by myasthenic sera. J Autoimnum 1989; 2:777-89.
29. Conroy WG, Saedi MS, Lindstrom J. TE671 cells express an abundance of a partially mature acetylcholine receptor α-subunit which has characteristics of an assembly intermediate. J Biol Chem 1990; 265:21642-51.
30. Green WN, Claudio T. Acetylcholine receptor assembly: subunit folding and oligomerization occur sequentially. Cell 1993; 74:57-69.
31. Ashizawa T, Ruan KH, Jinnai K, Atassi MZ. Profile of the regions on the alpha-chain of human acetylcholine receptor recognized by autoantibodies in myasthenia gravis. Mol Immunol 1992; 29:1507-14.
32. Talib S, Leiby KR, Wright K, Okarma TB. Cloning and expression in Escherichia coli of a synthetic gene encoding the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Gene 1991; 98:289-93.
33. Tzartos SJ, Sophianos D, Efthimiadis A. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab MoAb protects against antigenic modulation by human sera. J Immunol 1985; 134:2343-9.
34. Tzartos SJ, Langeberg L, Hochschwender S, Swanson L, Lindstrom J. Characteristics of monoclonal antibodies to denatured Torpedo and to native calf AChRs: species, subunit and region specilicity. J Neuroimmunol 1986; 10:235-53.
35. Heidenreich F, Vincent A, Willcox N, Newsom-Davis J. Anti-acetylcholine receptor antibody specificities in serum and in thymic cell culture supernatants from myasthenia gravis patients. Neurology 1988; 38:1784-8.
36. Beeson D, Amar M, Bermudez I, Vincent A, Newsom-Davis J. Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the epsilon subunit. Neurosci Lett 1996; 207:57-60.
37. Beeson D, Jacobson L, Newsom-Davis J, Vincent A. A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis. Neurology 1996; 47:1552-5.